Progesterone News and Research

RSS

Contraceptive pill may impair women's ability to recognize emotions

A new study suggests that a woman’s ability to read emotions may be negatively impacted by the contraceptive pill.

12 Feb 2019

New PET imaging agent may help measure efficacy or failure of hormone therapy for breast cancer

Physicians may soon have a new way to measure the efficacy or failure of hormone therapy for breast cancer patients, according to new research published in the February issue of The Journal of Nuclear Medicine.

12 Feb 2019

Phthalates may decrease fertility in female mice, study finds

A phthalate found in many plastic and personal care products may decrease fertility in female mice, a new study found.

8 Feb 2019

Researchers unravel path of metallodrug in a breast cancer cell

Some types of cancer cannot be treated with classical chemotherapy. Scientists from Inserm, CNRS, Sorbonne University, PSL university, University Grenoble Alpes and ESRF, the European Synchrotron, are working on a metallorganic molecule as an antitumor drug.

4 Feb 2019

The connection between the Pope and contraceptive pills

Millions of women around the world use the combined hormonal oral contraceptive pill whcih has been around the past six decades. The usual method advised is a 21 day cycle of the pill followed by a 7 day break when the woman bleeds.

22 Jan 2019

Contraceptive patch that could provide 6 months of contraception within seconds

Most birth control methods involving hormones involve daily intake of pills. Long acting contraceptive methods that involve implants or intrauterine devices (IUDs) need regular visits to the doctor and are not as acceptable to many women.

15 Jan 2019

Researchers identify potential target for new breast cancer treatments

Researchers from the School of Basic & Medical Biosciences have identified a potential target that could lead to new treatments for triple negative breast cancer.

18 Dec 2018

Two genomic tests help identify most effective treatment for breast cancer patients

New results from a long-running trial to identify which new drugs or combinations of drugs are most effective in which types of breast cancer, show that two genomic tests are bringing the era of truly personalized medicine ever nearer.

14 Nov 2018

Researchers develop powerful method to solve structures of small molecules

Small molecules -- from naturally occurring metabolites and hormones to synthetic medicines and pesticides -- can have big effects on living things. But for scientists to understand how the molecules work and how to design beneficial ones, they need to know the precise arrangement of atoms and chemical bonds.

9 Nov 2018

Researchers take first step in bioengineering human uterus to treat endometrial diseases

Researchers at Northwestern Medicine have taken the first step in bioengineering the human uterus to treat endometriosis, uterine-factor infertility and endometrial cancer.

1 Nov 2018

Hormone injections reduce risk for early menopause from breast cancer chemotherapy

Final results of SWOG Cancer Research Network's groundbreaking international Prevention of Early Menopause Study clinical trial are in, and they show continued evidence that women who get injections of the hormone drug goserelin along with standard breast cancer chemotherapy are more likely to become pregnant - without developing negative side effects or shortening their lives.

29 Oct 2018

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.

29 Oct 2018

Woman's PR-status may help develop personalized approach to treating endometriosis

Endometriosis -- a condition caused by uterine tissue growing outside of the organ -- affects 10% of reproductive-aged women, whom it causes chronic pain that is significant and debilitating.

25 Oct 2018

Gastric sleeve or bypass surgery can prevent womb cancer in obese women

A study of women who had gastric sleeve or bypass surgery for obesity has found that precancerous tissue in their womb reverted to normal tissue when they lost weight.

25 Oct 2018

FDA authorizes marketing of PicoAMH Elisa test to help determine woman's menopausal status

Today, the U.S. Food and Drug Administration permitted marketing of the PicoAMH Elisa diagnostic test as an aid in the determination of a patient's menopausal status.

25 Oct 2018

Biomarkers can predict treatment response in women with endometriosis

Biomarkers can predict whether women will respond to the first-line treatment for endometriosis, an extremely painful condition in which the tissue usually found inside the uterus grows in places it shouldn't, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

24 Oct 2018

Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer

Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the aromatase inhibitor letrozole significantly increases disease-free survival compared to tamoxifen in premenopausal women with hormone receptor positive (HR+) early breast cancer, according to results reported at ESMO 2018 Congress in Munich.

22 Oct 2018

Study: Neurons regulating reproductive hormone release have different activity in epileptic mice

Mice with epilepsy have altered patterns of neuron activity in the portion of the brain that controls the reproductive endocrine system, University of Illinois researchers report in a new study. Furthermore, the differences in neuron activity in female mice fluctuate across the reproductive cycle, the team found.

15 Oct 2018

New findings could benefit patients with triple-negative breast cancer

About 15 percent of breast cancers are classified as triple-negative, lacking receptors for estrogen, progesterone, and Her2.

12 Oct 2018

Nanoparticles show promise in treatment for triple-negative breast cancer, finds study

Approximately 10-20 percent of diagnosed breast cancers are found to be triple-negative, meaning the breast cancer cells test negative for estrogen and progesterone receptors as well as HER2 receptors, genes that can play a role in the development of breast cancer.

1 Oct 2018

Progesterone News and Research

Contraceptive pill may impair women's ability to recognize emotions

New PET imaging agent may help measure efficacy or failure of hormone therapy for breast cancer

Phthalates may decrease fertility in female mice, study finds

Researchers unravel path of metallodrug in a breast cancer cell

The connection between the Pope and contraceptive pills

Contraceptive patch that could provide 6 months of contraception within seconds

Researchers identify potential target for new breast cancer treatments

Two genomic tests help identify most effective treatment for breast cancer patients

Researchers develop powerful method to solve structures of small molecules

Researchers take first step in bioengineering human uterus to treat endometrial diseases

Hormone injections reduce risk for early menopause from breast cancer chemotherapy

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

Woman's PR-status may help develop personalized approach to treating endometriosis

Gastric sleeve or bypass surgery can prevent womb cancer in obese women

FDA authorizes marketing of PicoAMH Elisa test to help determine woman's menopausal status

Biomarkers can predict treatment response in women with endometriosis

Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer

Study: Neurons regulating reproductive hormone release have different activity in epileptic mice

New findings could benefit patients with triple-negative breast cancer

Nanoparticles show promise in treatment for triple-negative breast cancer, finds study

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News